Security
Avanos Medical, Inc. · AVNS
AVNSNYSECommon stockHistorical · closed Jul 27, 2026CIK 1606498Updated Oct 6, 2026
AVNS price & chart
This listing closed Jul 27, 2026. Live provider charts are shown only for current listings.
About the company
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to what matters. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple categories across its portfolio. For more information, visit avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.
In the news
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger ↗
Shareholder Alert: Ademi LLP investigates whether Avanos Medical Inc. is obtaining a Fair Price for Public Shareholders ↗
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avanos Medical, Inc. (NYSE: AVNS) ↗
Recent filings
15-12G filing
S-8 POS filing
SCHEDULE 13G - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding AVANOS MEDICAL, INC.
Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
4 filing
Show 5 more recent filings
4 filing
4 filing
Submission of Matters to a Vote of Security Holders · Regulation FD Disclosure
Items 5.07, 7.01, 9.01
DEFA14A filing
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,067,700,000Source | 1,656,200,000Source | 1,724,900,000Source | 1,039,000,000Source | 1,657,800,000Source | 1,050,100,000Source | 1,107,800,000Source | 1,661,300,000Source | 1,073,700,000Source | 1,154,200,000Source | 1,692,400,000Source | 1,786,900,000Source |
| Property, Plant and Equipment, NetUSD | 115,400,000Source | 109,500,000Source | 116,800,000Source | 114,300,000Source | 110,700,000Source | 111,200,000Source | 109,800,000Source | 116,200,000Source | 113,400,000Source | 110,700,000Source | 117,200,000Source | 163,900,000Source |
| GoodwillUSD | 394,400,000Source | 795,100,000Source | 791,500,000Source | 381,200,000Source | 794,400,000Source | 394,000,000Source | 455,900,000Source | 794,900,000Source | 394,900,000Source | 455,600,000Source | 796,100,000Source | 819,400,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 122,000,000Source | 220,100,000Source | 242,200,000Source | 105,400,000Source | 226,200,000Source | 114,700,000Source | 107,200,000Source | 232,800,000Source | 117,800,000Source | 112,300,000Source | 239,500,000Source | 251,000,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 70,500,000Source | 89,000,000Source | 107,100,000Source | 90,300,000Source | 92,200,000Source | 65,600,000Source | 97,000,000Source | 75,800,000Source | 89,800,000Source | 107,700,000Source | 87,700,000Source | 127,700,000Source |
| Accounts Receivable | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Inventory, NetUSD | 150,600,000Source | 161,900,000Source | 156,600,000Source | 142,700,000Source | 163,900,000Source | 141,300,000Source | 138,100,000Source | 165,600,000Source | 148,000,000Source | 138,800,000Source | 163,200,000Source | 190,300,000Source |
| Assets, CurrentUSD | 351,400,000Source | 472,600,000Source | 524,600,000Source | 356,000,000Source | 474,100,000Source | 325,000,000Source | 352,400,000Source | 467,800,000Source | 355,400,000Source | 393,400,000Source | 487,000,000Source | 499,800,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 18,800,000Source | 15,900,000Source | 13,600,000Source | 12,800,000Source | 22,300,000Source | 15,100,000Source | 12,500,000Source | 28,600,000Source | 13,800,000Source | 14,100,000Source | 28,800,000Source | 13,900,000Source |
| Operating Lease, Right-of-Use AssetUSD | 29,900,000Source | 26,500,000Source | 27,100,000Source | 31,100,000Source | 29,400,000Source | 39,300,000Source | 32,100,000Source | 24,200,000Source | 27,600,000Source | 34,100,000Source | 26,800,000Source | 30,600,000Source |
| Other Assets, NoncurrentUSD | 29,300,000Source | 25,800,000Source | 18,400,000Source | 25,700,000Source | 16,700,000Source | 32,900,000Source | 25,400,000Source | 19,100,000Source | 31,500,000Source | 23,200,000Source | 19,300,000Source | 17,600,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 289,700,000Source | 426,500,000Source | 502,800,000Source | 262,700,000Source | 435,800,000Source | 268,000,000Source | 268,400,000Source | 433,400,000Source | 295,500,000Source | 325,700,000Source | 456,100,000Source | 495,700,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 500,000Source |
| Additional Paid in CapitalUSD | 1,690,700,000Source | 1,674,700,000Source | 1,659,700,000Source | 1,686,900,000Source | 1,671,500,000Source | 1,696,000,000Source | 1,682,800,000Source | 1,667,700,000Source | 1,691,900,000Source | 1,678,600,000Source | 1,663,600,000Source | 1,646,400,000Source |
| Retained Earnings (Accumulated Deficit)USD | -778,600,000Source | -309,700,000Source | -325,400,000Source | -777,200,000Source | -314,000,000Source | -774,800,000Source | -700,400,000Source | -315,800,000Source | -779,900,000Source | -707,000,000Source | -314,900,000Source | -253,100,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -32,600,000Source | -36,900,000Source | -33,000,000Source | -32,000,000Source | -37,500,000Source | -36,000,000Source | -42,300,000Source | -29,500,000Source | -32,000,000Source | -44,600,000Source | -27,000,000Source | -35,800,000Source |
| Stockholders' Equity Attributable to ParentUSD | 778,000,000Source | 1,229,700,000Source | 1,222,100,000Source | 776,300,000Source | 1,222,000,000Source | 782,100,000Source | 839,400,000Source | 1,227,900,000Source | 778,200,000Source | 828,500,000Source | 1,236,300,000Source | 1,291,200,000Source |
| Liabilities and EquityUSD | 1,067,700,000Source | 1,656,200,000Source | 1,724,900,000Source | 1,039,000,000Source | 1,657,800,000Source | 1,050,100,000Source | 1,107,800,000Source | 1,661,300,000Source | 1,073,700,000Source | 1,154,200,000Source | 1,692,400,000Source | 1,786,900,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 147,900,000Source | 212,900,000Source | 170,700,000Source | 134,600,000Source | 208,200,000Source | 131,200,000Source | 137,200,000Source | 205,200,000Source | 165,200,000Source | 165,900,000Source | 234,600,000Source | 185,800,000Source |
| Operating Lease, Liability, CurrentUSD | 9,500,000Source | 13,700,000Source | 12,700,000Source | 10,400,000Source | 14,400,000Source | 10,400,000Source | 10,400,000Source | 11,500,000Source | 8,200,000Source | 10,900,000Source | 12,800,000Source | 12,800,000Source |
| Accounts Payable, CurrentUSD | 54,200,000Source | 54,200,000Source | 52,100,000Source | 48,800,000Source | 51,400,000Source | 52,300,000Source | 46,000,000Source | 57,000,000Source | 55,500,000Source | 54,300,000Source | 56,300,000Source | 67,900,000Source |
| Operating Lease, Liability, NoncurrentUSD | 21,400,000Source | 26,500,000Source | 29,500,000Source | 21,800,000Source | 28,800,000Source | 29,800,000Source | 23,100,000Source | 26,600,000Source | 20,400,000Source | 24,600,000Source | 28,300,000Source | 34,700,000Source |
| Deferred Income Tax Liabilities, NetUSD | 6,300,000Source | 23,900,000Source | 28,700,000Source | 6,300,000Source | 23,400,000Source | 5,600,000Source | 5,600,000Source | 23,600,000Source | 6,100,000Source | 5,500,000Source | 23,800,000Source | 25,400,000Source |
| Other Liabilities, NoncurrentUSD | 20,700,000Source | 10,600,000Source | 15,600,000Source | 4,300,000Source | 10,500,000Source | 14,100,000Source | 4,500,000Source | 10,800,000Source | 13,500,000Source | 4,400,000Source | 10,000,000Source | 23,500,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 74,800,000Source | 82,700,000Source | 97,200,000Source | 66,000,000Source | 79,500,000Source | 57,600,000Source | 71,400,000Source | 75,100,000Source | 91,300,000Source | 91,300,000Source | 93,200,000Source | 98,900,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 17,300,000Source | 20,800,000Source |
| Long-term DebtUSD | 93,400,000Source | 152,600,000Source | 258,300,000Source | 95,700,000Source | 164,900,000Source | 87,300,000Source | 98,000,000Source | 167,200,000Source | 90,300,000Source | 125,300,000Source | 159,400,000Source | 226,300,000Source |
| Long-term Debt, Current MaturitiesUSD | 9,400,000Source | 9,400,000Source | 6,200,000Source | 9,400,000Source | 10,200,000Source | 10,900,000Source | 9,400,000Source | 9,400,000Source | 10,200,000Source | 9,400,000Source | 8,600,000Source | 6,200,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 226,300,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 10,200,000Source | 9,600,000Source | 38,900,000Source | 45,500,000Source | 46,100,000Source | 47,700,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,700,000Source | 3,800,000Source | 12,600,000Source | 13,800,000Source | 15,800,000Source | 15,900,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 300,000Source | -25,100,000Source | -30,900,000Source | 6,600,000Source | -39,000,000Source | 24,700,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -6,100,000Source | -1,200,000Source | -200,000Source | -39,000,000Source | -4,700,000Source | 30,900,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -7,800,000Source | -35,900,000Source | -8,100,000Source | -3,700,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -12,300,000Source | 25,700,000Source | 74,700,000Source | 100,700,000Source | 32,400,000Source | 90,900,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 28,000,000Source | 0Source | 49,600,000Source | 116,100,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -7,700,000Source | -9,100,000Source | -60,600,000Source | -27,500,000Source | 21,600,000Source | -135,400,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 1,300,000Source | 2,200,000Source | 3,300,000Source | 12,800,000Source | 19,100,000Source | 45,500,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -3,200,000Source | -29,100,000Source | -37,000,000Source | -49,100,000Source | -94,200,000Source | 56,700,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -24,200,000Source | -10,700,000Source | -17,900,000Source | 20,000,000Source | -40,000,000Source | 9,200,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 70,500,000Source | 89,000,000Source | 90,300,000Source | 92,200,000Source | 65,600,000Source | 97,000,000Source | 89,800,000Source | 107,700,000Source | 87,700,000Source | 127,700,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 6,500,000Source | 11,500,000Source | 14,700,000Source | 8,100,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 14,100,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -1,000,000Source | 1,800,000Source | 5,000,000Source | -4,100,000Source | 200,000Source | -3,000,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 3,500,000Source | 2,600,000Source | 4,100,000Source | 3,800,000Source | 3,700,000Source | 3,800,000Source | 12,600,000Source | 13,800,000Source | 15,800,000Source | 15,900,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | 6,400,000Source | — | 6,300,000Source | — | 107,200,000Source | 19,200,000Source | 25,200,000Source | 24,300,000Source | 25,700,000Source |
| DepreciationUSD | — | — | 5,000,000Source | 5,300,000Source | 4,800,000Source | 5,000,000Source | 5,600,000Source | 4,500,000Source | 19,700,000Source | 20,300,000Source | 19,200,000Source | 22,000,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | -70,800,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | -9,300,000Source | -1,200,000Source | — | — |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | — | — | -1,900,000Source | -1,100,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | — | — | — | — | 6,900,000Source | — | — |
| GoodwillUSD | — | — | 394,400,000Source | 795,100,000Source | 381,200,000Source | 794,400,000Source | 394,000,000Source | 455,900,000Source | 394,900,000Source | 455,600,000Source | 796,100,000Source | 819,400,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 77,000,000Source | 436,700,000Source | — | — |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 77,000,000Source | 0Source | — | — | 77,000,000Source | — | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | — | — | 7,800,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,400,000Source | 5,900,000Source | -76,800,000Source | 4,300,000Source | — | 6,600,000Source | -72,900,000Source | -386,300,000Source | -9,900,000Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | -1,600,000Source | 0Source | -2,500,000Source | — | 0Source | 0Source | -5,800,000Source | -51,900,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 200,000Source | 3,600,000Source | 900,000Source | 1,900,000Source | 2,500,000Source | 3,100,000Source | 6,700,000Source | -17,000,000Source | 2,000,000Source | 14,700,000Source |
| InterestExpenseNonoperatingUSD | — | — | 1,800,000Source | 3,200,000Source | 2,000,000Source | 3,100,000Source | 1,500,000Source | 2,100,000Source | 7,800,000Source | 12,200,000Source | — | — |
| Inventory Write-downUSD | — | — | 2,100,000Source | 2,800,000Source | 2,000,000Source | 0Source | 3,300,000Source | 1,700,000Source | 9,400,000Source | 5,600,000Source | 5,100,000Source | — |
| Investment Income, InterestUSD | — | — | 500,000Source | 700,000Source | 600,000Source | 3,000,000Source | 200,000Source | 1,500,000Source | 3,200,000Source | 5,100,000Source | 2,900,000Source | 1,200,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,400,000Source | 4,300,000Source | -76,800,000Source | 1,800,000Source | 5,100,000Source | 6,600,000Source | -72,900,000Source | -392,100,000Source | -61,800,000Source | 50,500,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -2,300,000Source | 600,000Source | -300,000Source | -2,100,000Source | -2,400,000Source | 1,600,000Source | 400,000Source | 3,900,000Source | -13,300,000Source | -3,500,000Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 400,000Source | 400,000Source | 700,000Source | 1,100,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | — | — | — | — | — | — | — | — | — | — |
| Gain (Loss) on Disposition of Assets | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 177,800,000Source | 170,400,000Source | 175,000,000Source | 171,700,000Source | 182,200,000Source | 167,500,000Source | 701,200,000Source | 687,800,000Source | 673,300,000Source | 820,000,000Source |
| Cost of RevenueUSD | — | — | 91,800,000Source | 77,500,000Source | 82,900,000Source | 76,100,000Source | 88,000,000Source | 77,700,000Source | 347,300,000Source | 306,500,000Source | 293,600,000Source | 370,000,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 77,600,000Source | 74,300,000Source | 83,500,000Source | 80,900,000Source | 77,700,000Source | 75,700,000Source | 315,600,000Source | 318,500,000Source | 335,000,000Source | 341,900,000Source |
| Operating Income (Loss)USD | — | — | 100,000Source | 12,000,000Source | -74,500,000Source | 6,300,000Source | 8,900,000Source | 10,300,000Source | -61,600,000Source | -396,200,000Source | 4,200,000Source | 74,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,200,000Source | 9,500,000Source | -75,900,000Source | 6,200,000Source | 7,600,000Source | 9,700,000Source | -66,200,000Source | -403,300,000Source | -7,900,000Source | 65,200,000Source |
| Income Tax Expense (Benefit)USD | — | — | 200,000Source | 3,600,000Source | 900,000Source | 1,900,000Source | 2,500,000Source | 3,100,000Source | 6,700,000Source | -17,000,000Source | 2,000,000Source | 14,700,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,400,000Source | 4,300,000Source | -76,800,000Source | 1,800,000Source | 5,100,000Source | 6,600,000Source | -72,900,000Source | -392,100,000Source | -61,800,000Source | 50,500,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.03Source | 0.09Source | -1.66Source | 0.04Source | 0.11Source | 0.14Source | -1.57Source | -8.53Source | -1.32Source | 1.08Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.03Source | 0.09Source | -1.66Source | 0.04Source | 0.11Source | 0.14Source | -1.57Source | -8.53Source | -1.32Source | 1.07Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 46,400,000Source | 46,000,000Source | 46,300,000Source | 45,900,000Source | 46,500,000Source | 46,100,000Source | 46,300,000Source | 46,000,000Source | 46,600,000Source | 46,900,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 46,400,000Source | 46,600,000Source | 46,300,000Source | 46,300,000Source | 47,500,000Source | 46,800,000Source | 46,300,000Source | 46,000,000Source | 46,600,000Source | 47,300,000Source |
| Interest Expense (non-operating)USD | — | — | 1,800,000Source | 3,200,000Source | 2,000,000Source | 3,100,000Source | 1,500,000Source | 2,100,000Source | 7,800,000Source | 12,200,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 6,400,000Source | — | 6,300,000Source | — | 107,200,000Source | 19,200,000Source | 25,200,000Source | 24,300,000Source | 25,700,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 14,500,000Source | 18,900,000Source | 10,100,000Source | 18,400,000Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 0Source | 77,000,000Source | 0Source | — | — | 77,000,000Source | — | — | — |
| Gross ProfitUSD | — | — | 86,000,000Source | 92,900,000Source | 92,100,000Source | 95,600,000Source | 94,200,000Source | 89,800,000Source | 353,900,000Source | 381,300,000Source | 379,700,000Source | 450,000,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,400,000Source | 5,900,000Source | -76,800,000Source | 4,300,000Source | — | 6,600,000Source | -72,900,000Source | -386,300,000Source | -9,900,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -82,800,000Source | -421,500,000Source | -17,300,000Source | 59,300,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.03Source | 0.12Source | -1.66Source | 0.09Source | — | 0.14Source | -1.57Source | -8.4Source | -0.21Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.03Source | 0.12Source | -1.66Source | 0.09Source | — | 0.14Source | -1.57Source | -8.4Source | -0.21Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | -1,600,000Source | 0Source | -2,500,000Source | — | 0Source | 0Source | -5,800,000Source | -51,900,000Source | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 15,000,000Source | 10,000,000Source |
| Investment Income, InterestUSD | — | — | 500,000Source | 700,000Source | 600,000Source | 3,000,000Source | 200,000Source | 1,500,000Source | 3,200,000Source | 5,100,000Source | 2,900,000Source | 1,200,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -2,300,000Source | 600,000Source | -300,000Source | -2,100,000Source | -2,400,000Source | 1,600,000Source | 400,000Source | 3,900,000Source | -13,300,000Source | -3,500,000Source |
| Research and Development ExpenseUSD | — | — | 6,000,000Source | 7,200,000Source | 5,800,000Source | 6,300,000Source | 5,200,000Source | 5,400,000Source | 23,300,000Source | 26,200,000Source | 27,200,000Source | 30,600,000Source |
Filing attachments
avnsform8k_07272026xex991.htm · 8-K · 2026-07-30
EX-99.1 5 avnsform8k_07272026xex991.htm EX-99.1 Document Exhibit 99.1 American Industrial Partners Completes Acquisition of Avanos Medical, Inc. NEW YORK and ALPHARETTA, Ga., July 27, 2026 /PRNewswire/ - American Industrial Partners (“AIP”), an operationally-oriented industrials investor, today announced the closing of the acquisition of Avanos Medical, Inc. (“Avanos” or the “Company”) by affiliates of investment funds advised by AIP in a transaction valued at approximately $1.272 billion…
Read attachment ↗avnsform8k_07222026xex991.htm · 8-K · 2026-07-22
EX-99.1 2 avnsform8k_07222026xex991.htm EX-99.1 Document Exhibit 99.1 Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners ALPHARETTA, GA - July 22, 2026 - Avanos Medical, Inc. (NYSE: AVNS) (“Avanos” or the “Company”), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners (“AIP”) at a special meeting of sto…
Read attachment ↗avnsform8k_07022026xex991.htm · 8-K · 2026-07-02
EX-99.1 2 avnsform8k_07022026xex991.htm EX-99.1 Document Exhibit 99.1 Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger ALPHARETTA, GA and NEW YORK, NY - July 2, 2026/PRNewswire/ - Avanos Medical, Inc. (NYSE: AVNS) (“Avanos”) and American Industrial Partners (“AIP”) jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (t…
Read attachment ↗avns1q2026form8kex991.htm · 8-K · 2026-05-05
EX-99.1 2 avns1q2026form8kex991.htm EX-99.1 Document Investor Contact: Scott Galovan Avanos Medical, Inc. Investor. Relations@Avanos.com Media Contact: Katrine Kubis Avanos Medical, Inc. CorporateCommunications@Avanos.com Avanos Medical, Inc. Announces First Quarter 2026 Results • Delivered double-digit organic growth led by Specialty Nutrition Systems segment • Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per share • On April 14, 2026…
Read attachment ↗avnsform8k_04132026xex991.htm · 8-K · 2026-04-14
EX-99.1 3 avnsform8k_04132026xex991.htm EXHIBIT 99.1 Document Exhibit 99.1 Avanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 Billion Avanos Stockholders To Receive $25.00 Per Share in Cash ALPHARETTA, Ga., and NEW YORK - April 14, 2026 - Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners (“AIP”), a…
Read attachment ↗